Cargando…

Molecular Mechanism of YuPingFeng in the Treatment of Asthma Based on Network Pharmacology and Molecular Docking Technology

OBJECTIVE: To explore the molecular targets and mechanism of YuPingFeng (YPF) for the treatment of asthma by using network pharmacology and molecular docking. METHODS: The potential active ingredients and relevant targets of YPF were obtained from the Traditional Chinese Medicine Systems Pharmacolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Li, Lu, Jinmiao, Wang, Guangfei, Wang, Cheng, Li, Zhiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467798/
https://www.ncbi.nlm.nih.gov/pubmed/36105239
http://dx.doi.org/10.1155/2022/7364126
_version_ 1784788270171815936
author Shen, Li
Lu, Jinmiao
Wang, Guangfei
Wang, Cheng
Li, Zhiping
author_facet Shen, Li
Lu, Jinmiao
Wang, Guangfei
Wang, Cheng
Li, Zhiping
author_sort Shen, Li
collection PubMed
description OBJECTIVE: To explore the molecular targets and mechanism of YuPingFeng (YPF) for the treatment of asthma by using network pharmacology and molecular docking. METHODS: The potential active ingredients and relevant targets of YPF were obtained from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP). Asthma-related gene targets were retrieved from GeneCards, OMIM, DrugBank, PharmGKB, and TTD databases. The protein-protein (PPI) network between YPF and asthma common targets was constructed by SRING online database and Cytoscape software. GO and KEGG analyses were performed to explore the complicated molecular biological processes and potential pathways. Finally, a molecular docking approach was carried out to verify the results. RESULTS: We obtained 100 potential targets of the 35 active ingredients in YPF and 1610 asthma-related targets. 60 YPF-asthma common targets were selected to perform PPI analysis. Seven core genes were screened based on two topological calculation methods. GO and KEGG results showed that the main pathways of YPF in treating asthma include TNF signaling pathway and PI3K-Akt signaling pathway. Finally, the molecular docking results indicated that the key ingredients of YPF had a good affinity with the relevant core genes. CONCLUSION: This study reflects the multicomponent, multitarget, and multipathway characteristics of YPF in treating asthma, providing a theoretical and scientific basis for the intervention of asthma by traditional Chinese medicine YPF.
format Online
Article
Text
id pubmed-9467798
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-94677982022-09-13 Molecular Mechanism of YuPingFeng in the Treatment of Asthma Based on Network Pharmacology and Molecular Docking Technology Shen, Li Lu, Jinmiao Wang, Guangfei Wang, Cheng Li, Zhiping Comput Math Methods Med Research Article OBJECTIVE: To explore the molecular targets and mechanism of YuPingFeng (YPF) for the treatment of asthma by using network pharmacology and molecular docking. METHODS: The potential active ingredients and relevant targets of YPF were obtained from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP). Asthma-related gene targets were retrieved from GeneCards, OMIM, DrugBank, PharmGKB, and TTD databases. The protein-protein (PPI) network between YPF and asthma common targets was constructed by SRING online database and Cytoscape software. GO and KEGG analyses were performed to explore the complicated molecular biological processes and potential pathways. Finally, a molecular docking approach was carried out to verify the results. RESULTS: We obtained 100 potential targets of the 35 active ingredients in YPF and 1610 asthma-related targets. 60 YPF-asthma common targets were selected to perform PPI analysis. Seven core genes were screened based on two topological calculation methods. GO and KEGG results showed that the main pathways of YPF in treating asthma include TNF signaling pathway and PI3K-Akt signaling pathway. Finally, the molecular docking results indicated that the key ingredients of YPF had a good affinity with the relevant core genes. CONCLUSION: This study reflects the multicomponent, multitarget, and multipathway characteristics of YPF in treating asthma, providing a theoretical and scientific basis for the intervention of asthma by traditional Chinese medicine YPF. Hindawi 2022-09-05 /pmc/articles/PMC9467798/ /pubmed/36105239 http://dx.doi.org/10.1155/2022/7364126 Text en Copyright © 2022 Li Shen et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Shen, Li
Lu, Jinmiao
Wang, Guangfei
Wang, Cheng
Li, Zhiping
Molecular Mechanism of YuPingFeng in the Treatment of Asthma Based on Network Pharmacology and Molecular Docking Technology
title Molecular Mechanism of YuPingFeng in the Treatment of Asthma Based on Network Pharmacology and Molecular Docking Technology
title_full Molecular Mechanism of YuPingFeng in the Treatment of Asthma Based on Network Pharmacology and Molecular Docking Technology
title_fullStr Molecular Mechanism of YuPingFeng in the Treatment of Asthma Based on Network Pharmacology and Molecular Docking Technology
title_full_unstemmed Molecular Mechanism of YuPingFeng in the Treatment of Asthma Based on Network Pharmacology and Molecular Docking Technology
title_short Molecular Mechanism of YuPingFeng in the Treatment of Asthma Based on Network Pharmacology and Molecular Docking Technology
title_sort molecular mechanism of yupingfeng in the treatment of asthma based on network pharmacology and molecular docking technology
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467798/
https://www.ncbi.nlm.nih.gov/pubmed/36105239
http://dx.doi.org/10.1155/2022/7364126
work_keys_str_mv AT shenli molecularmechanismofyupingfenginthetreatmentofasthmabasedonnetworkpharmacologyandmoleculardockingtechnology
AT lujinmiao molecularmechanismofyupingfenginthetreatmentofasthmabasedonnetworkpharmacologyandmoleculardockingtechnology
AT wangguangfei molecularmechanismofyupingfenginthetreatmentofasthmabasedonnetworkpharmacologyandmoleculardockingtechnology
AT wangcheng molecularmechanismofyupingfenginthetreatmentofasthmabasedonnetworkpharmacologyandmoleculardockingtechnology
AT lizhiping molecularmechanismofyupingfenginthetreatmentofasthmabasedonnetworkpharmacologyandmoleculardockingtechnology